Does Dr. JONATHAN ABAYA GHAZALEH have financial conflicts of interest?

Dr. JONATHAN ABAYA GHAZALEH (MD) has received a total of $196 in pharmaceutical and medical device industry funding between 2021 and 2024. This includes $196 in personal promotional payouts (consulting, meals, travel) and $0 in clinical research grants. Financial ties do not automatically imply conflict of interest, but are disclosed under the Sunshine Act.

Which pharmaceutical companies pay Dr. JONATHAN ABAYA GHAZALEH?

According to CMS Open Payments data, Dr. JONATHAN ABAYA GHAZALEH received funding from ASTRAZENECA PHARMACEUTICALS ($150), TAKEDA PHARMACEUTICALS U.S.A ($25), and PHILIPS ELECTRONICS NORTH AMERICA CORPORATION ($21).

Does Dr. JONATHAN ABAYA GHAZALEH receive research grants or speaking fees?

Dr. JONATHAN ABAYA GHAZALEH has received $196 in general promotional payments (such as consulting honoraria, meals, and speaking fees) and $0 in clinical research grants.

DR. JONATHAN ABAYA GHAZALEH

MDReal-Time Hydrated

Specialty: Internal Medicine

Practice Location: VACAVILLE, CA 95688

NPI Number: 1093395535

LIFETIME INDUSTRY VALUE

$196

2021 – 2024 Cumulative

Conflict of Interest Analysis

Dr. ABAYA GHAZALEH is a verified Internal Medicine practitioner based in VACAVILLE, CA.

Between 2021 and 2024, Dr. ABAYA GHAZALEH had an overall industry promotional and research financial footprint of $196 as recorded in the federal CMS Open Payments database.

$196 was received in general payments, which include consultation fees, travel expenses, honoraria, and sponsored meals.
$0 was allocated to sponsored clinical trials and medical research activities.

Dr. ABAYA GHAZALEH's primary funding source is ASTRAZENECA PHARMACEUTICALS, which accounts for $150 (representing 76.7% of overall industry footprint).

Data coverage: 2021 – 2024 · Source: CMS Open Payments · CMS publishes each year's data around June 30 of the following year.

Payout Trend Over Time

General Payments

Research Funding

Top Funding Entities

Pharmaceutical & Device Manufacturers making direct payments

ASTRAZENECA PHARMACEUTICALS

Rank 1

$150

76.7%

TAKEDA PHARMACEUTICALS U.S.A

Rank 2

$25

12.7%

PHILIPS ELECTRONICS NORTH AMERICA CORPORATION

Rank 3

$21

10.6%

Itemized Transaction Archives

Direct live query to Socrata CMS Open Payments API (Bypasses local DB)

Year:

2024

Filter < $250

Click "Load Live Logs" to query the federal Open Payments registry directly.

Frequently Asked Questions

Answers compiled using federal transparency disclosure records under the Sunshine Act.